Ann: MND Biomarkers and Pharmacodynamics Results, page-86

After the recent trial update "quoted below", I had expected the p75 results before those announced today, as they were still pending at the time

The p75 ECD study results have now been received from Flinders University in Adelaide and will beformally interpreted by a pharmacologist and will be announced as soon as possible.An analysis being conducted at the Florey Institute in Melbourne evaluating p-RPS6KB1 and pEIF4EBP1 is still pending. Further, highly specialised testing of Neurofilament Light Chain (NfL) is beingconducted at the University of Tasmania which is expected in the coming weeks.

So
1/ We can expect the pharmacologist to conclude their interpretation of p75 soon, and this data released.
2/ NfL results in and published
3/ Cohort 2 results for p-RPS6KB1 and pEIF4EBp1 published

Triple punch coming your way.

Should this data all be overwhelming positive, surely the PR machine kicks into gear, FightMND start singing from the rooftops ( and so they should, what an effort ), and next steps announced by PAA, which must include a meeting with the FDA to have a chat about getting MPL to MND suffers ASAP.

Wow. All this for a $25M MC.